MindBio Therapeutics Corp. (CSE:MBIO)

MindBio Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Aug 15, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Market Capitalization	7	5	9	-
Market Cap Growth	-75.68%	-42.86%	-	-
Enterprise Value	11	10	12	-
Last Close Price	0.01	0.04	0.07	-
PB Ratio	-1.26	-1.01	-1.95	-
Debt / Equity Ratio	-0.82	-0.87	-0.92	-1.06
Quick Ratio	0.01	0.03	0.13	1.17
Current Ratio	0.01	0.03	0.23	1.35
Return on Assets (ROA)	-364.90%	-91.41%	-175.93%	-
Earnings Yield	-21.36%	-7.13%	-40.57%	-
Buyback Yield / Dilution	40.06%	-20.80%	-106.14%	-

Updated Jan 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.